Back to Search Start Over

Streptococcal superantigens and the return of scarlet fever.

Authors :
Hurst JR
Brouwer S
Walker MJ
McCormick JK
Source :
PLoS pathogens [PLoS Pathog] 2021 Dec 30; Vol. 17 (12), pp. e1010097. Date of Electronic Publication: 2021 Dec 30 (Print Publication: 2021).
Publication Year :
2021

Abstract

Streptococcus pyogenes (group A Streptococcus) is a globally disseminated and human-adapted bacterial pathogen that causes a wide range of infections, including scarlet fever. Scarlet fever is a toxin-mediated disease characterized by the formation of an erythematous, sandpaper-like rash that typically occurs in children aged 5 to 15. This infectious disease is caused by toxins called superantigens, a family of highly potent immunomodulators. Although scarlet fever had largely declined in both prevalence and severity since the late 19th century, outbreaks have now reemerged in multiple geographical regions over the past decade. Here, we review recent findings that address the role of superantigens in promoting a fitness advantage for S. pyogenes within human populations and discuss how superantigens may be suitable targets for vaccination strategies.<br />Competing Interests: The authors have declared that no competing interests exist.

Details

Language :
English
ISSN :
1553-7374
Volume :
17
Issue :
12
Database :
MEDLINE
Journal :
PLoS pathogens
Publication Type :
Academic Journal
Accession number :
34969060
Full Text :
https://doi.org/10.1371/journal.ppat.1010097